McGuire Veterans Administration Medical Center (VAMC), Richmond, Va; Virginia Commonwealth University, Richmond, Va.
Buffalo VAMC, NY.
Am J Med. 2024 May;137(5):442-448. doi: 10.1016/j.amjmed.2024.01.011. Epub 2024 Feb 1.
Recent studies have challenged the reported causal association between acute kidney injury and iodinated contrast administration, ascribing some cases to changes in renal function that are independent of contrast administration.
We studied 1779 consecutive patients undergoing right heart catheterization (RHC) at a Veterans Administration Medical Center. We compared the incidence of acute kidney injury and of nephropathy at 3 months in veterans undergoing right and left heart catheterization and coronary angiography (R&LHC) to the incidence of acute kidney injury and of nephropathy at 3 months in patients undergoing RHC only.
The incidence of acute kidney injury at 3 days was 47 (9.7%) in the R&LHC group and 58 (9.6%) in the RHC group (P = .99). The incidence of nephropathy at 3 months was 115 (17%) in the L&RHC group and 141 (19.2%) in the RHC group (P = 0.31). In a propensity score-paired analysis of 782 patients and after adjustment for baseline characteristics, the odds ratio for acute kidney injury at 3 days among patients undergoing R&LHC was 1.25 (95% confidence interval, 0.65-2.42; P = .50), and the odds ratio for nephropathy at 3 months was 0.69 (95% confidence interval, 0.46-1.04; P = .08).
The incidence of changes in creatinine consistent with acute kidney injury at 3 days and of nephropathy at 3 months was not significantly different in patients undergoing R&LHC compared with patients undergoing RHC only. This supports the thesis that not all changes in creatinine after procedures involving administration of contrast are caused by the contrast.
最近的研究对急性肾损伤与碘造影剂使用之间的报告因果关联提出了挑战,将一些病例归因于与造影剂使用无关的肾功能变化。
我们研究了在退伍军人事务医疗中心接受右心导管检查(RHC)的 1779 例连续患者。我们比较了接受右心和左心导管检查及冠状动脉造影(R&LHC)的退伍军人在 3 个月时急性肾损伤和肾病的发生率与仅接受 RHC 的患者在 3 个月时急性肾损伤和肾病的发生率。
R&LHC 组第 3 天急性肾损伤的发生率为 47(9.7%),RHC 组为 58(9.6%)(P=0.99)。L&RHC 组第 3 个月肾病的发生率为 115(17%),RHC 组为 141(19.2%)(P=0.31)。在对 782 例患者进行倾向评分匹配分析,并对基线特征进行调整后,R&LHC 患者第 3 天发生急性肾损伤的比值比为 1.25(95%置信区间,0.65-2.42;P=0.50),第 3 个月发生肾病的比值比为 0.69(95%置信区间,0.46-1.04;P=0.08)。
与仅接受 RHC 的患者相比,接受 R&LHC 的患者在第 3 天发生肌酐变化符合急性肾损伤的发生率和第 3 个月发生肾病的发生率无显著差异。这支持了并非所有造影剂使用后肌酐变化都是由造影剂引起的这一论点。